Company Filing History:
3 out of 5 
2 out of 10 
1 out of 2,012 
Years Active: 2002-2005
Title: The Innovative Contributions of Marco Guida
Introduction
Marco Guida is a prominent inventor based in San Diego, California. He has made significant contributions to the field of pharmacogenomics, particularly in the evaluation of drug metabolism. With a total of five patents to his name, Guida's work has the potential to impact the way pharmaceuticals are developed and administered.
Latest Patents
Among his latest patents, Guida has developed methods for evaluating the ability to metabolize pharmaceuticals. These methods focus on detecting variant genes that have polymorphisms associated with reduced metabolism of specific substrates, including CYP3A4 and CYP3A5. His innovative genotyping methods identify specific polymorphisms linked to reduced metabolism of chemotherapeutic agents, such as cyclophosphamide and BCNU. Additionally, he has disclosed novel polymorphic nucleic acid molecules that are useful in these methods. Another significant patent involves genetic typing of the human cytochrome P450 2A6 gene, where he has identified novel polymorphisms that serve as predictive sequences for altered metabolism or disease occurrence.
Career Highlights
Throughout his career, Marco Guida has worked with notable companies in the biotechnology sector. He has been associated with Dna Sciences Laboratories, Inc. and Genaissance Pharmaceuticals, Inc. His work in these organizations has allowed him to advance his research and contribute to the understanding of genetic factors in drug metabolism.
Collaborations
Guida has collaborated with esteemed colleagues, including Jeff Hall and Jay B Lichter. These partnerships have fostered a collaborative environment that enhances innovation and research in pharmacogenomics.
Conclusion
Marco Guida's contributions to the field of pharmacogenomics through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in personalized medicine and drug development.